Specialist Updates 
Oncology

Aspirin might accelerate cancer in the elderly

A detailed analysis of data on people taking aspirin for prophylaxis suggests the agent might hasten cancer deaths, researchers say
Clare Pain
0
13 August 2020
Save
aspirin tablets

Surprise findings from a landmark trial suggest that aspirin might accelerate the rate of progression of advanced malignancies in elderly people, researchers say.

The team conducted a post-hoc analysis of data from the ASPirin in Reducing Events in the Elderly (ASPREE) trial in which more than 19,000 people aged over 70 in Australia and the US were randomised to 100mg enteric-coated aspirin daily or placebo.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .